Fluvoxamine in the treatment of binge-eating disorder: A multicenter placebo-controlled, double-blind trial

American Journal of Psychiatry

Volumn 155, Issue 12, 1998, Pages 1756-1762

  Hudson, James I ^a   McElroy, Susan L ^b   Raymond, Nancy C ^b   Crow, Scott ^b   Keck Jr , Paul E ^b   Carter, William P ^b   Mitchell, James E ^b   Strakowski, Stephen M ^b   Pope Jr , Harrison G ^b   Coleman, Bernard S ^b   Jonas, Jeffrey M ^b  

^a MCLEAN HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; FLUVOXAMINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; PLACEBO; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; ASTHENIA; BINGE EATING DISORDER; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DREAM; FEMALE; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NERVOUSNESS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SIDE EFFECT; SOMNOLENCE; TREATMENT OUTCOME; VERTIGO; XEROSTOMIA;

EID: 0031791461     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.155.12.1756     Document Type: Article

References (31)

1. Stunkard AJ: Eating patterns and obesity. Psychiatr Q 1959; 33:284-292
2. de Zwaan M, Mitchell JE, Raymond NC, Spitzer RL: Binge eating disorder: clinical features and treatment of a new diagnosis. Harvard Rev Psychiatry 1994; 1:310-325
3. Spitzer RL, Devlin M, Walsh BT, Hasin D, Wing R, Marcus M, Stunkard A, Wadden T, Yanovski S, Agras S, Mitchell J, Nonas C: Binge eating disorder: a multisite field trial of the diagnostic criteria. Int J Eating Disorders 1992; 11:191-203
4. Spitzer RL, Yanovski S, Wadden T, Wing R, Marcus MD, Stunkard A, Devlin M, Mitchell J, Hasin D, Horne RL: Binge eating disorder: its further validation in a multisite study. Int J Eating Disorders 1993; 13:137-153
5. Yanovski SZ, Nelson JE, Dubbert BK, Spitzer RL: Association of binge eating disorder and psychiatric comorbidity in obese subjects. Am J Psychiatry 1993; 150:1472-1479
6. Hudson JI, Carter WP, Pope HG Jr: Antidepressant treatment of binge-eating disorder: research findings and clinical guidelines. J Clin Psychiatry 1996; 57(suppl 8):73-79
7. Bruce B, Agras WS: Binge eating in females: a population-based investigation. Int J Eating Disorders 1992; 12:365-373
8. Stunkard A, Berkowitz R, Tanrikut C, Reiss E, Young L: d-Fenfluramine treatment of binge eating disorder. Am J Psychiatry 1996; 153:1455-1459
9. McCann UD, Agras WS: Successful treatment of nonpurging bulimia nervosa with desipramine: a double-blind, placebo-controlled study. Am J Psychiatry 1990; 147:1509-1513
10. Fluoxetine Bulimia Nervosa Collaborative Study Group: Fluoxetine in the treatment of bulimia nervosa: a multicenter, placebo-controlled, double-blind trial. Arch Gen Psychiatry 1992; 49:139-147
11. Goldstein DJ, Wilson MG, Thompson VL, Potving JH, Rampey AH, Fluoxetine Bulimia Nervosa Research Group: Long-term fluoxetine treatment of bulimia nervosa. Br J Psychiatry 1995; 166:660-666
12. Mitchell JE, Raymond N, Specker S: A review of the controlled trials of pharmacotherapy and psychotherapy in the treatment of bulimia nervosa. Int J Eating Disorders 1993; 14:229-247
13. Hudson JI, Carter WP, Pope HG Jr: Pharmacologic therapy of bulimia nervosa, in The Management of Eating Disorders. Edited by Goldstein DJ. Totowa, NJ, Humana Press (in press)
14. Prats M, Diez-Quevedo C, Avila C, Planell LS: Paroxetine treatment for bulimia nervosa and binge eating disorder, in Abstracts of the Sixth International Conference on Eating Disorders. New York, Montefiore Medical Center, April 1994, abstract number 308
15. Gardiner HM, Freeman CPL, Jesinger KD, Collins SA: Fluvoxamine: an open pilot study in moderately obese female patients suffering from atypical eating disorders and episodes of bingeing. Int J Obesity 1993; 17:301-305
16. Metropolitan Life Insurance Company: 1983 Metropolitan height and weight tables. Stat Bull Metrop Life Found 1983; 64:3-9
17. Spitzer RL, Williams JBW, Gibbon M, First MB: Instruction Manual for the Structured Clinical Interview for DSM-III-R (SCID). New York, New York State Psychiatric Institute, Biometrics Research, 1989
18. Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6:278-296
19. SAS/STAT Software: Changes and Enhancements Through Release 6.12. Cary, NC, SAS Institute, 1997
20. Gibbons RD, Hedeker D, Elkin I, Waternaux C, Kraemer HC, Greenhouse JB, Shea MT, Imber SD, Sotsky SM, Watkins JT: Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Arch Gen Psychiatry 1993; 50:739-750
21. Cnaan A, Laird NM, Slasor P: Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data. Stat Med 1997; 16:2349-2380
22. Alger SA, Schwalberg MD, Bigaouette JM, Michalek AV, Howard LJ: Effect of a tricyclic antidepressant and opiate antagonist on binge-eating behavior in normal weight bulimic and obese, binge-eating subjects. Am J Clin Nutr 1991; 53: 865-871
23. Marcus MD, Wing RR, Ewing L, Kern E, McDermott M, Gooding W: A double-blind, placebo-controlled trial of fluoxetine plus behavior modification in the treatment of obese binge-eaters and non-binge-eaters. Am J Psychiatry 1990; 147: 876-881
24. Agras WS, Telch CF, Arnow B, Edlredge K, Wilfley DE, Raeburn SD, Henderson J, Marnell M: Weight loss, cognitive-behavioral, and desipramine treatments in binge-eating disorder: an additive design. Behavior Therapy 1994; 25:225-238
25. Fichter MM, Krüger R, Rief W, Holland R, Döhne J: Fluvoxamine in prevention of relapse in bulimia nervosa: effects on eating-specific psychopathology. J Clin Psychopharmacol 1996; 16:9-18
26. Freeman CP: Fluvoxamine: clinical trials and clinical use. J Psychiatr Neurosci 1991; 16 (suppl 1):19-25
27. Hudson JI, Pope HG Jr: Affective spectrum disorder: does antidepressant response identify a family of disorders with a common pathophysiology? Am J Psychiatry 1990; 147:552-564
28. Pope HG Jr, Hudson JI, Jonas JM: Antidepressant treatment of bulimia: preliminary experience and practical recommendations. J Clin Psychopharmacol 1983; 3:274-281
29. Pope HG Jr, Hudson JI, Jonas JM, Yurgelun-Todd D: Antidepressant treatment of bulimia: a two-year follow-up study. J Clin Psychopharmacol 1985; 5:320-327
30. Mitchell JE, Pyle RL, Eckert ED, Hatsukami D, Pomeroy C, Zimmerman R: Response to alternative antidepressants in imipramine nonresponders with bulimia nervosa. J Clin Psychopharmacol 1989; 9:291-293
31. March JS, Kobak KA, Jefferson JW, Mazza J, Greist JH: A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression. J Clin Psychiatry 1990; 51:200-202